Latest Period
Q4 2025
CUSIP: 92337C203
Latest Period
Q4 2025
Institutions Reporting
141
Shares (Excl. Options)
76,499,371
Price
$7.72
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 141 institutions filings for Q4 2025.
What is CUSIP 92337C203?
CUSIP 92337C203 identifies VSTM - Verastem, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 92337C203:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 9.9% | 0% | $60,496,591 | +$17,057,672 | 7,836,346 | +39% | RTW Investments, LP | 31 Dec 2025 |
| Deep Track Capital, LP | 10% | $60,288,436 | 7,719,390 | Deep Track Capital, LP | 14 Nov 2025 | |||
| BALYASNY ASSET MANAGEMENT L.P. | 6.2% | -35% | $36,802,429 | -$7,341,998 | 4,767,154 | -17% | Balyasny Asset Management L.P. | 31 Dec 2025 |
| Nantahala Capital Management, LLC | 4.7% | -34% | $29,301,052 | -$6,413,490 | 3,795,473 | -18% | Nantahala Capital Management, LLC | 31 Dec 2025 |
| BlackRock, Inc. | 6% | +22% | $32,479,205 | +$10,231,285 | 3,676,905 | +46% | BlackRock, Inc. | 30 Sep 2025 |
| ARMISTICE CAPITAL, LLC | 5.3% | $27,297,920 | 3,536,000 | Armistice Capital, LLC | 31 Dec 2025 | |||
| Polar Capital Holdings Plc | 5.1% | $36,130,293 | 3,398,899 | Polar Capital Holdings Plc | 31 Dec 2025 | |||
| Soleus Capital Master Fund, L.P. | 7.3% | $23,421,337 | 3,350,692 | Soleus Capital Management, L.P. | 31 Dec 2024 | |||
| Logos Global Management LP | 4.8% | -23% | $28,035,250 | -$2,207,500 | 3,175,000 | -7.3% | Logos Global Management LP | 30 Sep 2025 |
| Foresite Capital Fund VI LP | 5.1% | $27,693,456 | 3,135,120 | Foresite Capital Fund VI LP | 16 Oct 2025 | |||
| Stonepine Capital Management, LLC | 4.3% | -14% | $23,576,383 | -$1,441,948 | 2,670,032 | -5.8% | Stonepine Capital Management, LLC | 30 Sep 2025 |
| BIOTECHNOLOGY VALUE FUND L P | 3.9% | -61% | $11,850,000 | -$15,266,739 | 2,500,000 | -56% | BVF PARTNERS L P/IL | 11 Aug 2025 |
| HIRSCHMAN ORIN | 3.6% | -42% | $8,298,970 | -$2,960,715 | 2,003,179 | -26% | Orin Hirschman | 30 Jun 2025 |
| ORBIMED ADVISORS LLC | 2.4% | -53% | $6,319,998 | -$7,248,005 | 1,333,333 | -53% | ORBIMED ADVISORS LLC | 30 Jun 2025 |
| Alyeska Investment Group, L.P. | 2.1% | $6,990,000 | 1,000,000 | Alyeska Investment Group, L.P. | 31 Dec 2024 | |||
| Point72 Asset Management, L.P. | 1.3% | -80% | $7,681,601 | -$18,090,994 | 995,026 | -70% | Point72 Asset Management, L.P. | 31 Dec 2025 |
| Soleus Private Equity Fund III, L.P. | 1.8% | $6,541,375 | 935,819 | Soleus Capital Management, L.P. | 31 Mar 2025 |
As of 31 Dec 2025, 141 institutional investors reported holding 76,499,371 shares of Verastem, Inc. - Common Stock (VSTM). This represents 115% of the company’s total 66,716,981 outstanding shares.
The largest institutional shareholders of Verastem, Inc. - Common Stock (VSTM) together control 95% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 9.9% | 6,576,306 | +21% | 0.51% | $50,769,082 |
| Deep Track Capital, LP | 8.6% | 5,740,850 | 1% | $44,319,362 | |
| BlackRock, Inc. | 7.1% | 4,752,842 | +28% | 0% | $36,691,941 |
| VANGUARD GROUP INC | 6.2% | 4,152,706 | +19% | 0% | $32,058,890 |
| Polar Capital Holdings Plc | 5.9% | 3,925,126 | +271% | 0.14% | $30,301,973 |
| ARMISTICE CAPITAL, LLC | 5.3% | 3,536,000 | +69% | 0.67% | $27,297,920 |
| STATE STREET CORP | 4.8% | 3,219,295 | +44% | 0% | $24,852,957 |
| Balyasny Asset Management L.P. | 4.8% | 3,195,726 | -23% | 0.05% | $24,671,005 |
| Foresite Capital Management VI LLC | 4.7% | 3,135,120 | +20% | 7.3% | $24,203,126 |
| Stonepine Capital Management, LLC | 4.1% | 2,732,079 | +2.3% | 17% | $21,091,650 |
| CITADEL ADVISORS LLC | 3.5% | 2,353,465 | +1173% | 0.01% | $18,168,750 |
| FARALLON CAPITAL MANAGEMENT LLC | 3% | 2,000,000 | 0.09% | $15,440,000 | |
| SymBiosis Capital Partners, LLC | 3% | 2,000,000 | 0% | 16% | $15,440,000 |
| MORGAN STANLEY | 2.8% | 1,871,562 | +18% | 0% | $14,448,459 |
| Rosalind Advisors, Inc. | 2.7% | 1,788,475 | -7.3% | 5.3% | $13,807,027 |
| Logos Global Management LP | 2.5% | 1,700,000 | -58% | 0.87% | $13,124,000 |
| GOLDMAN SACHS GROUP INC | 2.2% | 1,495,424 | +504% | 0% | $11,544,673 |
| ACORN CAPITAL ADVISORS, LLC | 2.2% | 1,469,153 | +88% | 3.8% | $11,341,861 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1% | 1,392,822 | +12% | 0% | $10,755,389 |
| NEXTBio Capital Management LP | 2% | 1,307,330 | 0% | 5.9% | $10,092,588 |
| Vivo Capital, LLC | 1.7% | 1,106,524 | -58% | 0.55% | $8,542,365 |
| TANG CAPITAL MANAGEMENT LLC | 1.6% | 1,069,810 | +35% | 0.41% | $8,258,933 |
| Point72 Asset Management, L.P. | 1.5% | 995,026 | -74% | 0.01% | $7,681,601 |
| J. Goldman & Co LP | 1.4% | 947,303 | +129% | 0.28% | $7,313,179 |
| FRANKLIN RESOURCES INC | 1.4% | 926,011 | 0% | $7,148,805 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 9,249,514 | $49,024,049 | +$11,017,502 | $5.30 | 38 |
| 2025 Q4 | 76,499,371 | $590,570,869 | +$94,102,234 | $7.72 | 141 |
| 2025 Q3 | 59,623,619 | $526,453,168 | +$99,234,089 | $8.83 | 117 |
| 2025 Q2 | 52,579,871 | $218,248,088 | +$27,001,542 | $4.15 | 108 |
| 2025 Q1 | 43,276,151 | $260,961,400 | +$53,029,028 | $6.03 | 98 |
| 2024 Q4 | 33,863,058 | $175,077,129 | +$45,200,535 | $5.17 | 90 |
| 2024 Q3 | 26,590,058 | $80,398,256 | +$34,219,258 | $2.99 | 76 |
| 2024 Q2 | 14,536,365 | $43,320,696 | -$62,700,412 | $2.98 | 66 |
| 2024 Q1 | 16,867,597 | $198,997,762 | +$3,544,853 | $11.80 | 69 |
| 2023 Q4 | 16,678,830 | $135,764,956 | -$559,497 | $8.14 | 57 |
| 2023 Q3 | 16,747,399 | $136,152,780 | +$6,463,854 | $8.13 | 56 |
| 2023 Q2 | 16,115,155 | $119,896,447 | +$119,896,447 | $7.44 | 59 |